Key Market Segments:
By Product
-
- Standard Pen Needles
- Safety Pen Needles
By Needle Length
-
- 4mm
- 5mm
- 6mm
- 8mm
- 10mm
- 12mm
By Therapy
-
- Insulin
- Glucagon-like-peptide-1
- Growth Hormone
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online channels
By End-Use
- Hospitals and clinics
- Home care settings
- Other end-users
Request for Segment Customization as per your Business Requirement: https://www.snsinsider.com/sample-request/7708
Regional Coverage:
North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Poland
- Turkey
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Request for Country Level Research Report: https://www.snsinsider.com/sample-request/7708
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: North America dominated the Pen Needles Market in 2024.
Ans: BD (Becton, Dickinson and Company), Novo Nordisk A/S, Terumo Corporation, Owen Mumford Ltd., Ypsomed Holding AG, Allison Medical, Inc., HTL-Strefa S.A. (a MTD Group company), Artsana S.p.A. (Pic Solution), Arkray, Inc., UltiMed, Inc., and other players.
Ans: Advancements in needle technology are propelling the market growth.
Ans: The Pen Needles Market is expected to grow at a CAGR of 10.26%.
Ans: The Pen Needles Market was valued at USD 3.42 billion in 2024 and is expected to reach USD 7.43 billion by 2032.